Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01359735 · ClinicalTrials.gov registry record · Phase 2

Healing Effects of HP802-247 Versus Antibiotic Ointment in Mohs Micrographic Surgery Patients

A Phase 2 study, sponsored by Healthpoint.

Completed
Registry status
Phase 2
Development phase
8
Enrollment target

NCT01359735 is a Phase 2 study that has completed, run by Healthpoint. The registered enrollment target is 8 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01359735, a Phase 2 study, has completed, sponsored by Healthpoint.

COMPLETED
Registry status
Phase 2
Development phase
8 participants
Enrollment target

Study Summary

This study compares HP802-247 versus an antibiotic ointment for healing the wound after Mohs surgery.

Interventions

  • BIOLOGICAL HP802-247
  • BIOLOGICAL Bacitracin Ointment

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2011-05
Est. Completion 2012-05
Phase Phase 2

Sponsor

Healthpoint

25 total trials

What the Registry Record Tells You About NCT01359735

The ClinicalTrials.gov registry entry for NCT01359735 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Healthpoint, which has 25 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which HP802-247 is the first listed.

NCT01359735 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01359735 about?

NCT01359735 is a clinical study titled "Healing Effects of HP802-247 Versus Antibiotic Ointment in Mohs Micrographic Surgery Patients". This study compares HP802-247 versus an antibiotic ointment for healing the wound after Mohs surgery.

What is the current status of trial NCT01359735?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 8 participants. The study started on 2011-05. Estimated completion is 2012-05.

What interventions are being tested in trial NCT01359735?

The interventions under investigation include: HP802-247 (BIOLOGICAL), Bacitracin Ointment (BIOLOGICAL).

Who is sponsoring clinical trial NCT01359735?

This trial is sponsored by Healthpoint, which has 25 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.